Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverum Biotechnologies Inc.

http://adverum.com

Latest From Adverum Biotechnologies Inc.

Appointments: News From GSK, DBV Technologies, Complexa, Synlogic And Motif Bio

This week’s announcements include the retirement of GlaxoSmithKline’s CFO, new CEOs at Complexa, Synlogic and Horizon Discovery, and other new hires at TP Therapeutics and Motif Bio, and a new board member at DBV Technologies.

Appointments BioPharmaceutical

Appointments: Rice Goes To CVS, A New CFO At J&J And Changes at Merck & Co, Alder, Hansa, OncoMed, Modus Therapeutics, Astellas Americas And Others

This week's new appointments include the move by the second former big pharma executive to a PBM in the space of a week, plus a new CFO at Johnson & Johnson, and new CEOs at Alder BioPharmaceuticals, OncoMed and Hansa Medical. Other hires were announced by Astellas Americas, Merck & Co, Valbiotis, Bicycle Therapeutics, Sorrento Therapeutics, Gritstone Oncology and Oxford BioMedica. 

 

Appointments BioPharmaceutical

Pharma Justifies Steep Prices, Plans Fancy Footwork In The Era Of Cures

BioMarin CMO Geoff Nichol envisions "fancy footwork" in future payer negotiations for groundbreaking hemophilia therapy, during a discussion on value at the 2018 Biotech Showcase meeting, held in conjunction with the J.P. Morgan conference.

Regenerative Medicine Pricing Strategies

Pipeline Watch: Phase III Starts With Tesetaxel, Molidustat, Imeglimin

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Approvals Pipeline Watch
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Site Specific
  • Therapeutic Areas
  • Cardiovascular
  • Immune Disorders
  • Inflammation
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Adverum Biotechnologies Inc.
  • Senior Management
  • Leone Patterson, CEO
    Thomas Leung, CFO
    Mehdi Gasmi, PhD, Pres. & CSO
    Aaron Osborne, CMO
  • Contact Info
  • Adverum Biotechnologies Inc.
    Phone: (650) 272-6269
    1035 O’Brien Dr., Ste. A
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register